Medicare Policy at the Crossroads: Addressing Artificial Intelligence and Software
AdvaMed® collaborated with CapView Strategies to develop this new report on improving coverage and payment for AI/software in Medicare. This work builds on the analysis and recommendations from an earlier collaboration. As described in the first report, CMS has the regulatory flexibility to incorporate digital health technologies—including AI/software innovations—into its payment pathways as the statutory parameters for Medicare’s benefit categories accommodate evidence-based, digital health solutions. This second report updates the previous analysis with a specific focus on AI/software.
Related Reading
News / Coverage & Payment / Health Access / Regulatory Affairs
AdvaMed Welcomes Expiration of Moratorium on New Medicare Durable Medical Equipment Suppliers
August 27, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, today welcomed the expiration of the moratorium on Medicare acceptance of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) suppliers. He made the following comment on the expiration.
Blog / Artificial Intelligence (AI) / Digital Health / Health Access
The Insight Series: AI & Digital Health with Kelly Huang
August 27, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. This edition features Kelly Huang, CEO of Elucid, an AI medical technology company focused on providing physicians with a more precise, non-invasive view of atherosclerosis to drive patient-specific cardiovascular care.
Event / Artificial Intelligence (AI) / Regulatory Affairs
Quality and Regulatory at the Speed of AI: Moving Faster Without Losing Trust
September 24, 2026
12:00 PM – 1:00 PM
Join Suntra MedTech as they explore how AI is beginning to reshape the work of Quality and Regulatory—and what must not change.
Resource / Coverage & Payment / Regulatory Affairs
AdvaMed® Comments on FDA-2016-D-1307 Communications with Payors
August 7, 2026
AdvaMed’s recent submission to the Food and Drug Administration (FDA) provides comments on the Agency’s revised draft guidance governing communications between drug and device manufacturers and payors, formulary committees, and similar entities.
Resource / Coverage & Payment / Government & Legislative Affairs / Health Access
Gateways to Health: How Medtech Is Improving Care While Lowering Healthcare Costs
July 31, 2026
Read Gateways to Health, a special publication exploring how medical technology improves patient care, expands access, and lowers healthcare costs.
Blog / Artificial Intelligence (AI) / Diagnostics / Digital Health / Health Access
The Insight Series: AI & Digital Health
July 27, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. Our latest edition features Jacque Engle, Vice President of Marketing & Communication and Juli Goldstein, Vice President of Government Affairs & Market Access at Digital Diagnostics.
News / Coverage & Payment / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access / Regulatory Affairs
AdvaMed Statement on the Klomp Nomination
June 26, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the largest trade association representing medtech innovators, posted his statement on LinkedIn regarding the nomination of Chris Klomp as deputy secretary of the Department of Health and Human Services.
Blog / Coverage & Payment / Digital Health / Government & Legislative Affairs / Health Access / Regulatory Affairs
Essential Tremor Treatment: A Sensible Solution, Possibly Driven Out of Reach
June 22, 2026
Millions of Americans have the neurological condition essential tremor. Often, that means their hand shakes so badly, they can’t hold a pen, fork, or glass of water. Every activity of daily living is compromised, day and night.